Lars Lund

Lars H Lund

Associate Professor and Senior Consultant

Karolinska Insitutet and Karolinska University Hospital, Sweden

Biography

Dr Lund's expertise is in HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilisation of existing evidence-based interventions in heart failure with reduced ejection fraction, as well as in novel interventions.

Dr Lars Lund is an Editorial Board member of Cardiac Failure Review.

Read more

Media

Play Icon
2021 ESC Clinical Practice Recommendations on the use of SGLT-2 Inhibitors in Heart Failure: An Assessment of their Impact

Andrew JS Coats, Lars H Lund, Michele Senni, et al

Andrew JS Coats, Carolyn Lam, Felipe Martínez, et al

image

Lars H Lund,

Lars Lund - SGTL2i beyond diabetes

Lars H Lund,

Heart Failure With Mid Ejection Fraction In CHARM with Lars Lund

Lars H Lund,

Articles

Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies

Tonje Thorvaldsen, Lars H Lund,

Published:

Citation: Cardiac Failure Review 2019;5(1):24–6.

DOI:

https://doi.org/10.15420/cfr.2018.35.1
Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM

Lars H Lund,

Citation: Cardiac Failure Review 2018;4(2):70–2.

DOI:

https://doi.org/10.15420/cfr.2018.11.2
Global Public Health Burden of Heart Failure

Gianluigi Savarese, Lars H Lund,

Citation: Cardiac Failure Review 2017;3(1):7–11.

DOI:

https://doi.org/10.15420/cfr.2016:25:2
Congestion and Diuretic Resistance in Acute or Worsening Heart Failure

Ingibjörg Kristjánsdóttir, Tonje Thorvaldsen, Lars H Lund, et al

Published:

Citation: Cardiac Failure Review 2020;6:e25.

DOI:

https://doi.org/10.15420/cfr.2019.18